LENNOX GASTAUT SYNDROME
Clinical trials for LENNOX GASTAUT SYNDROME explained in plain language.
Never miss a new study
Get alerted when new LENNOX GASTAUT SYNDROME trials appear
Sign up with your email to follow new studies for LENNOX GASTAUT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New epilepsy drug shows promise in long-term safety trial for rare seizure disorders
Disease control CompletedThis study looked at the long-term safety of an experimental drug called LP352 in people aged 12 to 65 with severe epilepsy syndromes like Dravet and Lennox-Gastaut. All 41 participants had already completed an earlier study and continued treatment for up to 52 weeks. Researchers…
Matched conditions: LENNOX GASTAUT SYNDROME
Phase: PHASE2 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 06:47 UTC
-
New hope for rare seizure sufferers: Long-Term drug safety confirmed
Disease control CompletedThis study looked at the long-term safety of a drug called fenfluramine (ZX008) for people with rare seizure disorders like Dravet syndrome and Lennox-Gastaut syndrome. Over 400 participants who had already been in earlier studies took the drug for an extended period. The main go…
Matched conditions: LENNOX GASTAUT SYNDROME
Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated May 26, 2026 06:44 UTC